期刊文献+

大豆苷元对去卵巢大鼠血脂及肝脏ERα和LDLR表达的影响

Effects of Different Doses of Daidzein on Serum Lipids and Liver LDLR Expression in Ovariectomized Rats
原文传递
导出
摘要 目的:探讨不同剂量大豆苷元对绝经后血脂的保护作用。方法:选用4月龄SD雌性大鼠66只,随机分为:假手术组(Sham)、去势组(OVX)、戊酸雌二醇组(E2)、大豆苷元高剂量(H-Dai,200mg/kg)组、中剂量(M-Dai,50mg/kg)组和低剂量(L-Dai,10mg/kg)组,每组11只。于去势术后4周开始分别给予相应的药物灌胃,3个月后处死大鼠,取血和肝脏,检测血清甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-c)、高密度脂蛋白胆固醇(HDL-c),以及肝脏ERα和LDLRmRNA的表达量。结果:与OVX组相比,大豆苷元可以降低血清LDL-c,且随着剂量的增加其作用更明显(P<0.01);大剂量可以降低血清TG(P<0.05)。大豆苷元还增加肝脏ERα和LDLRmRNA的表达量,且也有剂量依赖效应,低、中剂量组与高剂量组差异显著(P<0.01)。结论:大豆苷元对去势大鼠血脂有一定保护作用,其降低血清LDL-c的作用可能是通过ERα途径增加LDLR的表达而实现的。 Objective: To explore the protective effect of daidzein with different dosage on serum lipids after menopause. Methods: Sixty-six Sprague-Dawley female rats aged 4 months were divided into six groups randomly (n = 11). Four weeks later, Sham group and control OVX group were administreed with distilled water, whereas the other groups received valerate estriol (800 μg/kg) and different doses of daidzein (low dose, 10 mg/kg; medium dose, 50 mg/kg; high does, 200 mg/kg) by gavage for 3 months respectively. Serum TG, LDL-c, HDL-c and liver ERa, LDLR mRNA expression were measured after the sacrifice of the rats. Results: Compared with OVX group, daidzein could lower serum LDL-c(P〈0.01), this effect in the high-dose group was more significant than that in the low-dose or medium-dose group, high-dose daidzein could lower serum TG (P〈0.05). Daidzein increased ERa, LDLR mRNA expression in the liver, and the effect was more significant with the dose increased. Conclusion: Daidzein exerts some protective effects on serum lipids, the LDL-c-lowering effect may be attributed to the increase of LDLR expression, which may be realized through the ERα pathway.
出处 《生殖与避孕》 CAS CSCD 北大核心 2009年第7期461-465,共5页 Reproduction and Contraception
基金 上海市科委项目(编号:04JC14092) 上海市医学重点学科建设项目(项目规划书编号:05III016)
关键词 大豆苷元 去势大鼠 血脂 低密度脂蛋白受体 daidzein ovariectomized rat serum lipids LDLR
  • 相关文献

参考文献4

二级参考文献42

  • 1范建高 曾民德 等.上海市4009名机关职员脂肪肝流行病学调查[J].中华肝脏病杂志,1998,6(1):17-17.
  • 2赵水平(Zhao SP).临床血脂学[M]. 第1版. 湖南:湖南科技出版社,1997.
  • 3叶平(Ye P).血脂的基础与临床[M]. 第1版 . 北京:人民军医出版社,2002. 329-330.
  • 4Glazia MG,Bowman MA. A review of the evidence for the use of phytoestrogen for traditional estrogen replacement therapy [J]. Arch Inter Med,2001,9(16):1161-1171.
  • 5Takehiko Uesugi,Toshiya TODA. Comparative study on reduction of bone and lipid metabolism abnormality in ovariectomized rat by soy isoflavones,daidzin,genistin,and glycitin [J]. Biol Pharm Bull,2000,24(4):368-372.
  • 6Folch J,Lees M,Sloane Stanley GH. A simple methods for the isolation and purification of total lipids from animal tissues[J]. J Biol Chem,1957,226:497.
  • 7Thorndike EA,Turner AS. In search of an animal model for postmenopauseal dieases [J]. Front Biosci,1998,16(3):c17-26.
  • 8Pederson SB. The effect of estrogen on glucose tolerance and insulin [J]. Mol Cell Endocrinol,1999,85(10):13-19.
  • 9Michael RP.A cooperative interaction between soy protein and its isoflavone-enriched fraction lowers hepatic lipids in male obese zucker rats and reduces blood platelet sensitivity in male sprague-dawley rats [J]. Am Soc Nutr Sci,2000.2333-2342.
  • 10Iritani N. Soybean protein suppresses hepatic lipogenic enzyme gene expression in Wistar fatty rats [J]. J Nutr,1996,126:380-388.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部